Skip to content
Thursday 30 July 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
City PM

European business, markets and politics

FTSE 100
10,908.41
+0.34%
DAX
25,460.48
0.00%
CAC 40
8,408.27
0.00%
STOXX 50
6,248.84
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Sponsored Ad Feature is produced by an advertiser with the specific intent to promote a product and is not produced by the City PM team.
Monday 05 July 2021 9:00 am  |  Updated:  Friday 02 July 2021 4:04 pm

Treatments to reduce and remove acne scars

By:

Add as a preferred source on Google

According to the NHS, 95% of people aged 11 to 30 will experience acne at some point — a figure that drops to 3% after 35. But even after acne has healed people can be left with scars. 

The London Dermatology Clinic is a specialist centre for treating acne scars with world renowned and award-winning doctors at the helm, utilising an array of treatment options such as laser, micro needling, TCA cross and subcision needling.

Book a consultation with one of the acne specialist dermatologists and start your journey with a bespoke treatment plan curated for your skin.

Find out more: londondermatologyclinic.com/skin-conditions/acne-scar-removal

Read more

Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Categories

  • Life&Style

Trending Articles

  • Big Four’s AIM exodus accelerates as mid-tier firms seize mandates

  • EY and London managing partner fined over £1.3m for audit failure

  • Lloyd’s of London allows staff to work from home as heatwave hits the capital

  • PwC thought leadership reports ‘100 per cent AI generated’

  • FTSE 100 firm agrees £5.7bn takeover in latest private equity swoop

More from City PM

  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • The physical capital paradox: why the best performing asset class is the least owned

    Opinion
    Diversified Energy Company said it would pay for the sale with a $35m share issuance.
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Almirall H1 2026 Results

    Business Wire
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults

    Business Wire
  • Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

    Business Wire
CityPM

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About City PM
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 City PM Ltd · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook